Delivery Order SPE2DB22D3016-SPE2DB25FBJR8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,209.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector packs (2-count). This competitively awarded, non-set-aside delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and operates under firm fixed pricing. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,533.52 and a completion date of September 18, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal supply arrangement. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,856.40 delivery order contract to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed price, competitively awarded delivery order is expected to be completed by September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order represents a task issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,096.35. This firm fixed-price delivery order, awarded April 30, 2025, with a completion date of May 1, 2025, represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,703.31 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,882.98 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed price, competitively awarded delivery order was executed on September 15, 2025, with an ultimate completion date of September 16, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement,...
- The Defense Logistics Agency awarded a $2,927.97 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This non-set-aside, competitively awarded contract is classified as a Delivery Order under a Firm Fixed Price arrangement, with an ultimate completion date of September 10, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,477.10 and an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.22 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJR8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,560.55 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for ultimate completion on September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated capability to meet DLA requirements across multiple therapeutic domains and product categories, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/17/25 |